+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anti-GFP Nanobody Immunomagnetic Beads Market - Global Forecast 2026-2032- Product Image
Anti-GFP Nanobody Immunomagnetic Beads Market - Global Forecast 2026-2032- Product Image
Sale

Anti-GFP Nanobody Immunomagnetic Beads Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6133162
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Anti-GFP Nanobody Immunomagnetic Beads Market is projected to reach USD 503.68 Million in 2026. It is expected to continue growing at a CAGR of 5.11%, reaching USD 678.56 Million by 2032.

Anti-GFP Nanobody Immunomagnetic Beads: Executive Summary

Anti-GFP nanobody immunomagnetic beads combine the selective binding of GFP-directed nanobodies with magnetic separation, supporting enrichment, isolation, pull-down, and purification workflows for GFP-tagged proteins and complexes. Their value is tied to reproducibility, binding specificity, low background, compatibility with small sample volumes, and ease of integration into laboratory automation. Applications span cell biology, protein research, microscopy-linked workflows, assay development, and bioprocess-support activities. Adoption decisions typically depend on bead capacity, nanobody orientation, linker chemistry, particle characteristics, buffer tolerance, protocol speed, and validation quality.

Workflow Integration Is Reshaping GFP-Tagged Sample Processing

The landscape is shifting from manually intensive affinity capture toward standardized, scalable, and automation-compatible workflows. Researchers increasingly prioritize consistent recovery, reduced nonspecific binding, minimal sample handling, and compatibility with downstream analysis such as immunoblotting, mass spectrometry, microscopy, and sequencing. Smaller sample volumes and more complex experimental designs also increase the importance of high-affinity capture and gentle elution conditions.

Product differentiation is therefore moving beyond simple magnetic separation. Performance is assessed through lot-to-lot consistency, bead uniformity, shelf stability, protocol flexibility, and documentation of binding behavior across commonly used buffers and sample types. Laboratories with shared instrumentation are particularly attentive to reproducibility, operator simplicity, and integration with liquid-handling systems.

Artificial Intelligence Improves Design, Screening, and Experimental Interpretation

Artificial intelligence is influencing this field indirectly but materially. Machine-learning tools can support protein-structure analysis, nanobody sequence prioritization, affinity optimization, and prediction of interactions between binding reagents and GFP variants. These capabilities may shorten experimental screening cycles and help identify candidates with improved selectivity, stability, or performance under challenging assay conditions.

AI is also being applied to experimental planning and data interpretation. Automated image analysis can quantify enrichment or localization, while laboratory informatics can compare recovery, background, and reproducibility across protocols. However, computational predictions do not replace empirical validation. Researchers still need orthogonal testing across GFP constructs, sample matrices, buffer systems, and downstream detection methods, with careful controls for nonspecific adsorption and magnetic carryover.

Regional Insights: Research Infrastructure Drives Uneven Adoption

North America combines strong biomedical research capacity, established biotechnology activity, and broad use of automated laboratory workflows, supporting demand for validated affinity tools. Europe benefits from dense academic networks, advanced life-science infrastructure, and emphasis on reproducibility and laboratory quality. Asia-Pacific is supported by expanding research capabilities, investment in biotechnology, and growing adoption of high-throughput methods, although purchasing access and protocol standardization vary by country.

Latin America shows opportunity where university, clinical-research, and biotechnology laboratories are strengthening molecular biology capabilities, but procurement cycles, import requirements, and technical support can influence adoption. The Middle East is developing research and translational infrastructure, with demand concentrated in well-equipped institutions and innovation hubs. Africa presents a more heterogeneous environment, in which access to instrumentation, cold-chain logistics, training, and dependable supply are central considerations.

Group Insights: Multilateral and Economic Blocs Shape Research Access

ASEAN laboratories are expanding regional biotechnology activity, while differences in infrastructure, procurement systems, and technical training create varied readiness for advanced magnetic separation workflows. BRICS members represent diverse research ecosystems with increasing interest in domestic capability, scalable laboratory methods, and access to specialized reagents. The European Union places strong emphasis on research collaboration, quality systems, data integrity, and cross-border laboratory compatibility.

G7 countries generally have mature life-science infrastructure, established automation practices, and demanding expectations for validation and documentation. GCC members are strengthening biotechnology and research capacity through institutional investment, with adoption likely to be concentrated in specialized centers. NATO members span highly developed and developing research environments; their common relevance is strongest in collaborative scientific networks, procurement resilience, and the need for reliable laboratory supply chains.

Country Insights: Capability, Procurement, and Research Priorities Differ

The United States and Canada have broad academic, biotechnology, and core-facility capabilities, supporting sophisticated affinity-capture workflows and demand for reproducibility. The United Kingdom, Germany, France, Italy, and Spain benefit from established molecular biology communities and advanced research institutions, while regulatory expectations and institutional procurement processes shape implementation. Australia combines strong biomedical research with geographic supply-chain considerations.

China, Japan, South Korea, and India are strengthening life-science research and biomanufacturing capabilities, with interest in scalable and automation-ready sample preparation. Brazil and Mexico serve as important Latin American research markets, but access, import procedures, and local technical support can affect workflow continuity. Russia’s research environment is influenced by supply-chain constraints and institutional access to specialized reagents. Across these countries, successful adoption depends on validated protocols, dependable distribution, and compatibility with local laboratory equipment and practices.

Recommendations for Leaders: Win Through Validation, Usability, and Resilience

Industry leaders should establish performance specifications that cover capture efficiency, nonspecific binding, GFP-variant compatibility, elution behavior, bead recovery, and lot-to-lot consistency. Validation should use representative sample matrices and downstream applications rather than relying only on idealized buffer tests. Clear protocols, control recommendations, troubleshooting guidance, and transparent technical documentation can reduce implementation friction.

Product development should prioritize automation compatibility, low-volume workflows, stable storage, and flexible operating conditions. Regional strategies should account for distributor capability, import requirements, technical training, and continuity of supply. Leaders should also use AI selectively for reagent design, protocol optimization, and image or assay analysis while retaining experimental controls, traceability, and human review. Partnerships with core facilities and research institutions can generate application evidence and reveal unmet workflow needs.

Research Methodology: Evidence-Based Assessment of Workflow Drivers

This executive summary uses a qualitative assessment framework focused on the technical role of anti-GFP nanobody immunomagnetic beads in laboratory sample preparation and affinity capture. The analysis considers product attributes, experimental use cases, workflow integration, automation readiness, reproducibility requirements, regional research infrastructure, procurement conditions, and the influence of computational tools.

Regional, group, and country observations are framed as structural insights rather than numerical market claims. They reflect differences in biotechnology capacity, laboratory investment, research networks, supply-chain conditions, and adoption requirements. Interpretation should be validated against current primary evidence, including peer-reviewed studies, institutional protocols, product performance documentation, laboratory interviews, procurement records, and regulatory or quality-system materials.

Conclusion: Reliable Affinity Capture Supports More Reproducible GFP Workflows

Anti-GFP nanobody immunomagnetic beads address a practical need for selective, efficient, and repeatable handling of GFP-tagged biomolecules and samples. Their relevance is increasing as laboratories seek smaller-volume processing, automation, cleaner enrichment, and stronger integration with imaging, proteomics, and other downstream analyses. Competitive advantage will depend on demonstrated performance, protocol simplicity, documentation, and supply reliability rather than binding claims alone.

The most resilient approach is to combine rigorous validation with application-specific support and regionally appropriate access models. Laboratories and suppliers that emphasize reproducibility, interoperability, responsible use of AI, and transparent evidence will be best positioned to advance adoption across diverse research environments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Anti-GFP Nanobody Immunomagnetic Beads Market, by Magnetic Property
7.1. Introduction
7.2. Paramagnetic
7.3. Superparamagnetic
8. Anti-GFP Nanobody Immunomagnetic Beads Market, by Surface Chemistry
8.1. Introduction
8.2. Nanobody Conjugation
8.2.1. Anti-Flag Nanobody
8.2.2. Anti-GFP Nanobody
8.2.3. Anti-HA Nanobody
8.2.4. Anti-His Nanobody
8.3. Protein A/G Coating
8.4. Streptavidin Coating
9. Anti-GFP Nanobody Immunomagnetic Beads Market, by Particle Size
9.1. Introduction
9.2. Micro
9.3. Nano
10. Anti-GFP Nanobody Immunomagnetic Beads Market, by Application
10.1. Introduction
10.2. Cell Separation
10.3. Diagnostic Assays
10.4. Flow Cytometry
10.5. Protein Purification
11. Anti-GFP Nanobody Immunomagnetic Beads Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Contract Research Organizations
11.4. Diagnostic Laboratories
11.5. Pharmaceutical Biotechnology Companies
12. Anti-GFP Nanobody Immunomagnetic Beads Market, by Sales Channel
12.1. Introduction
12.2. Online
12.3. Offline
13. Anti-GFP Nanobody Immunomagnetic Beads Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Anti-GFP Nanobody Immunomagnetic Beads Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Anti-GFP Nanobody Immunomagnetic Beads Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abcam plc
17.2. Bio-Rad Laboratories, Inc.
17.3. Chromotek GmbH
17.4. Creative Biolabs, Inc.
17.5. Creative Diagnostics LLC
17.6. GenScript Biotech Corporation
17.7. NanoTag Biotechnologies GmbH
17.8. Proteintech Group, Inc.
17.9. Sino Biological Inc.
17.10. Thermo Fisher Scientific Inc.
17.11. Wuhan Dia-An Biotechnology Co., Ltd.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Anti-GFP Nanobody Immunomagnetic Beads Market, Years Considered for the Study
FIGURE 2. Global Anti-GFP Nanobody Immunomagnetic Beads Market, Research Design
FIGURE 3. Global Anti-GFP Nanobody Immunomagnetic Beads Market, Research Framework
FIGURE 4. Global Anti-GFP Nanobody Immunomagnetic Beads Market, Data Triangulation
FIGURE 5. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2025 vs 2032 (%)
FIGURE 7. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2025 vs 2032 (%)
FIGURE 9. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2025 vs 2032 (%)
FIGURE 11. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 17. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Anti-GFP Nanobody Immunomagnetic Beads Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Anti-GFP Nanobody Immunomagnetic Beads Market Segmentation & Coverage
TABLE 2. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 3. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 4. Global Paramagnetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Paramagnetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Paramagnetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Superparamagnetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Superparamagnetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Superparamagnetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 11. Global Nanobody Conjugation Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Nanobody Conjugation Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Nanobody Conjugation Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Anti-Flag Nanobody Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Anti-Flag Nanobody Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Anti-Flag Nanobody Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Anti-GFP Nanobody Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Anti-GFP Nanobody Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Anti-GFP Nanobody Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Anti-HA Nanobody Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Anti-HA Nanobody Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Anti-HA Nanobody Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Anti-His Nanobody Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Anti-His Nanobody Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Anti-His Nanobody Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Protein A/G Coating Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Protein A/G Coating Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Protein A/G Coating Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Streptavidin Coating Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Streptavidin Coating Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Streptavidin Coating Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 33. Global Micro Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Micro Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Micro Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Nano Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Nano Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Nano Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 40. Global Cell Separation Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Cell Separation Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Cell Separation Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Diagnostic Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Diagnostic Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Diagnostic Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Protein Purification Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Protein Purification Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Protein Purification Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Pharmaceutical Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Pharmaceutical Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Pharmaceutical Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 66. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 81. North America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. North America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 83. North America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 84. North America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 85. North America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 86. North America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 87. North America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. North America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 89. Latin America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Latin America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 91. Latin America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 92. Latin America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 93. Latin America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 94. Latin America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. Latin America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Latin America Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 97. Europe Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Europe Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 99. Europe Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 100. Europe Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 101. Europe Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 102. Europe Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Europe Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Europe Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 105. Middle East Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Middle East Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 107. Middle East Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 108. Middle East Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 109. Middle East Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 110. Middle East Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. Middle East Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Middle East Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 113. Africa Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Africa Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 115. Africa Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 116. Africa Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 117. Africa Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 118. Africa Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. Africa Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. Africa Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 121. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. ASEAN Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. ASEAN Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 124. ASEAN Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 125. ASEAN Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 126. ASEAN Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 127. ASEAN Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. ASEAN Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. ASEAN Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 130. GCC Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. GCC Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 132. GCC Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 133. GCC Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 134. GCC Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 135. GCC Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. GCC Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. GCC Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 138. European Union Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. European Union Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 140. European Union Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 141. European Union Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 142. European Union Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 143. European Union Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. European Union Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. European Union Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 146. BRICS Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. BRICS Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 148. BRICS Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 149. BRICS Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 150. BRICS Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 151. BRICS Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. BRICS Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. BRICS Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 154. G7 Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. G7 Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 156. G7 Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 157. G7 Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 158. G7 Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 159. G7 Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. G7 Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. G7 Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 162. NATO Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. NATO Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 164. NATO Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 165. NATO Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 166. NATO Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 167. NATO Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. NATO Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. NATO Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 170. Global Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. United States Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 172. United States Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 173. United States Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 174. United States Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 175. United States Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 176. United States Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. United States Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. United States Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 179. Canada Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 180. Canada Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 181. Canada Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 182. Canada Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 183. Canada Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 184. Canada Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Canada Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Canada Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 187. Mexico Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 188. Mexico Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 189. Mexico Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 190. Mexico Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 191. Mexico Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 192. Mexico Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. Mexico Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Mexico Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 195. Brazil Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 196. Brazil Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 197. Brazil Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 198. Brazil Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 199. Brazil Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 200. Brazil Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Brazil Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Brazil Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 203. United Kingdom Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 204. United Kingdom Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 205. United Kingdom Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 206. United Kingdom Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 207. United Kingdom Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 208. United Kingdom Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. United Kingdom Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. United Kingdom Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 211. Germany Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 212. Germany Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 213. Germany Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 214. Germany Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 215. Germany Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 216. Germany Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Germany Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Germany Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 219. France Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 220. France Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 221. France Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 222. France Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 223. France Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 224. France Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. France Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. France Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 227. Russia Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 228. Russia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 229. Russia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 230. Russia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 231. Russia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 232. Russia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. Russia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Russia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 235. Italy Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 236. Italy Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 237. Italy Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 238. Italy Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 239. Italy Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 240. Italy Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. Italy Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Italy Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 243. Spain Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 244. Spain Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 245. Spain Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 246. Spain Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 247. Spain Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 248. Spain Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. Spain Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Spain Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 251. China Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 252. China Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 253. China Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 254. China Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 255. China Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 256. China Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 257. China Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. China Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 259. India Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 260. India Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 261. India Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 262. India Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 263. India Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 264. India Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. India Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. India Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 267. Japan Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 268. Japan Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 269. Japan Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 270. Japan Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 271. Japan Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 272. Japan Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. Japan Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Japan Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 275. Australia Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 276. Australia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 277. Australia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 278. Australia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 279. Australia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 280. Australia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. Australia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. Australia Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 283. South Korea Anti-GFP Nanobody Immunomagnetic Beads Market Size, 2017-2032 (USD Million)
TABLE 284. South Korea Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Magnetic Property, 2017-2032 (USD Million)
TABLE 285. South Korea Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Surface Chemistry, 2017-2032 (USD Million)
TABLE 286. South Korea Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Nanobody Conjugation, 2017-2032 (USD Million)
TABLE 287. South Korea Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Particle Size, 2017-2032 (USD Million)
TABLE 288. South Korea Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. South Korea Anti-GFP Nanobody Immunomagnetic Beads Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. South Korea Anti-GFP Nanobody Immunomagnetic Beads Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 291. Global Anti-GFP Nanobody Immunomagnetic Beads Market Share, by Key Player, 2025
TABLE 292. Global Anti-GFP Nanobody Immunomagnetic Beads Market, Key Experts

Companies Mentioned

  • Abcam plc
  • Bio-Rad Laboratories, Inc.
  • Chromotek GmbH
  • Creative Biolabs, Inc.
  • Creative Diagnostics LLC
  • GenScript Biotech Corporation
  • NanoTag Biotechnologies GmbH
  • Proteintech Group, Inc.
  • Sino Biological Inc.
  • Thermo Fisher Scientific Inc.
  • Wuhan Dia-An Biotechnology Co., Ltd.

Related Topics

Related Reports

Anti-GFP Nanobody Market - Global Forecast 2026-2032 - Product Image

Anti-GFP Nanobody Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
VHH Nanobodies Market - Global Forecast 2026-2032 - Product Image

VHH Nanobodies Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Nanobodies Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Nanobodies Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Nanobodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Nanobodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Nanobody-Based Diagnostics Global Market Report 2026 - Product Image

Nanobody-Based Diagnostics Global Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.